Progressive endothelial cell damage in an inflammatory model of pulmonary hypertension.
Monocrotaline (MCT)-induces progressive disruption of endothelial cell membrane and caveolin-1 leading to pulmonary arterial hypertension (PAH). Treatment instituted early rescues caveolin-1 and attenuates PAH. To test the hypothesis that the poor response to therapy in established PAH is due to progressive deregulation of multiple signaling pathways, the authors investigated time-dependent changes in the expression of caveolin-1, gp130, PY-STAT3, Bcl-xL, and the molecules involved in NO signaling pathway (endothelial nitric oxide synthase [eNOS], heat sock protein 90 [HSP90], Akt, soluble guanylate cyclase [sGC] alpha1 and beta1 subunits). PAH and right ventricular hypertrophy (RVH) were observed at 2 and 3 weeks. Progressive loss of endothelial caveolin-1 and sGC (alpha1, beta1), PY-STAT3 activation, and Bcl-xL expression were observed at 1 to 3 weeks post-MCT. The expression of gp130 increased at 48 hours and 1 week, with a subsequent loss at 2 and 3 weeks. The expression of eNOS increased at 48 hours and 1 week post-MCT, with a significant loss at 3 weeks. The expression of HSP90 and Akt decreased at 2 and 3 weeks post-MCT concomitant with PAH. Thus, MCT induces progressive loss of membrane and cytosolic proteins, resulting in the activation of proliferative and antiapoptotic factors, and deregulation of NO signaling leading to PAH. An attractive therapeutic approach to treat PAH may be an attempt to rescue endothelial cell membrane integrity.
Section of Pediatric Cardiology, Maria Fareri Children's Hospital at Westchester Medical Center and New York Medical College, Valhalla, New York 10595, USA.
Jing
J
Huang
John H
JH
Wolk
Michael H
MH
Gewitz
Rajamma
R
Mathew
D000818:Animals; D003600:Cytosol / Q000737:chemistry; D018450:Disease Progression; D042783:Endothelial Cells / Q000473:pathology*; D015870:Gene Expression; D006976:Hypertension, Pulmonary / Q000473:pathology*; D007249:Inflammation / Q000473:pathology*; D008297:Male; D008565:Membrane Proteins / Q000032:analysis; D016686:Monocrotaline / Q000633:toxicity; D009569:Nitric Oxide / Q000378:metabolism; D011506:Proteins / Q000032:analysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D015398:Signal Transduction; D013997:Time Factors
D008565:Membrane Proteins; D011506:Proteins; D009569:Nitric Oxide; D016686:Monocrotaline